Clinical trial
MK0928 Phase IIb Dose-range Finding Study -Primary Insomnia
NCT00266344 is registered in ClinicalTrials.gov with H. Lundbeck A/S as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- MK0928 Phase IIb Dose-range Finding Study -Primary Insomnia
- Lead sponsor
- H. Lundbeck A/S
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- November 30, 2005
- Completion date
- October 31, 2006
- Enrollment
- 520
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
primary insomnia